Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants

Clinical trial NCT02641041 · COMPLETED

Trial details

NCT number: NCT02641041
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Central Nervous System (CNS) Demyelinating Disease Multiple Sclerosis

Start date: 2016-02-01
Primary completion: 2016-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.